<em>trans</em>-Ned-19

trans-Ned-19

CAT N°: 17527
Price:

From 66.00 56.10

Nicotinic acid adenine dinucleotide phosphate (NAADP) is a dinucleotide second messenger that triggers the release of calcium from lysosomes and related cellular compartments.{28523} trans-Ned-19 is a structural analog of NAADP that blocks NAADP-dependent calcium release (IC50 = 6 nM) as well as NAADP binding to sea urchin egg homogenate (IC50 = 0.4 nM).{28527} The trans form of Ned-19 is significantly more potent than the cis isomer in both assays.{28527} Ned-19 does not affect either IP3-mediated calcium release or cyclic ADP-ribose-mediated calcium release.{28527} It directly binds NAADP receptors on lysosomes in mouse pancreatic beta cells and competitively antagonizes activation by NAADP.{28527,28526} It inhibits glucose-induced calcium oscillations in pancreatic islets and insulin-induced calcium increases in 3T3-L1 adipocytes.{28527,28525} Ned-19 also blocks calcium signaling induced by endothelin-1 or norepinephrine in renal afferent arterioles.{28424} Ned-19 dose-dependently reduces infection of host cells by Ebola virus.{28524}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • (1R,3S)-1-[3-[[4-(2-fluorophenyl)-1-piperazinyl]methyl]-4-methoxyphenyl]-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid
  • Correlated keywords
    • 874374-25-1 1137264-00-6 1137263-70-7 biochemical receptor antagonist signal transduction diabetes metabolic syndrome antiviral intracellular signaling nicotinic acid adenine dinucleotide phosphate NAADP NAADP-dependent binding calcium release dinucleotide sea urchin egg homogenate lysosomes trans ned19 dose-dependently reduce infection Ebola virus inhibit glucose-induced oscillation insulin-induced 3T3-L1 adipocyte
  • Product Overview:
    Nicotinic acid adenine dinucleotide phosphate (NAADP) is a dinucleotide second messenger that triggers the release of calcium from lysosomes and related cellular compartments.{28523} trans-Ned-19 is a structural analog of NAADP that blocks NAADP-dependent calcium release (IC50 = 6 nM) as well as NAADP binding to sea urchin egg homogenate (IC50 = 0.4 nM).{28527} The trans form of Ned-19 is significantly more potent than the cis isomer in both assays.{28527} Ned-19 does not affect either IP3-mediated calcium release or cyclic ADP-ribose-mediated calcium release.{28527} It directly binds NAADP receptors on lysosomes in mouse pancreatic beta cells and competitively antagonizes activation by NAADP.{28527,28526} It inhibits glucose-induced calcium oscillations in pancreatic islets and insulin-induced calcium increases in 3T3-L1 adipocytes.{28527,28525} Ned-19 also blocks calcium signaling induced by endothelin-1 or norepinephrine in renal afferent arterioles.{28424} Ned-19 dose-dependently reduces infection of host cells by Ebola virus.{28524}

We also advise you